...
首页> 外文期刊>Urologia internationalis >Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?
【24h】

Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?

机译:初次活检时的炎症模式是否表明在反复进行饱和前列腺活检时降低前列腺癌的风险?

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: To evaluate if an inflammatory pattern at primary biopsy is associated with a lower risk for cancer in men submitted to repeated saturation prostate biopsy (SPBx). Methods: From January 2005 to January 2010, 320 patients, after a negative primary extended biopsy (median 18 cores), underwent SPBx by transperineal approach performing 27 cores (median). 210 (65.6%) patients had a normal parenchyma and 110 had an inflammatory pattern (34.4%) at primary biopsy (none of them complained of symptoms suggesting a diagnosis of acute prostatitis at the time of biopsy). Moreover, median prostate-specific antigen and abnormal digital rectal examination was equal to 7.3 ng/ml and 3.6% versus 8.2 ng/ml and 3.8%, respectively. Results: Prostate cancer (PCa) was found in 66 (20.5%) of 320 patients. Of these, 42 (63.6%) and 24 (36.4%; p = 0.007) had a histological diagnosis of chronic prostatitis and normal parenchyma at primary biopsy, respectively. Conclusions: An inflammatory pattern at primary biopsy is not associated with a decrease in PCa incidence at repeated SPBx; therefore, only an accurate clinical evaluation including more parameters (i.e. urinary PCA3) could hopefully select men who need to undergo rebiopsy in the presence of persistent suspicion of cancer.
机译:简介:为了评估在接受反复饱和前列腺活检(SPBx)的男性中,初次活检的炎症模式是否与较低的癌症风险相关。方法:自2005年1月至2010年1月,对320例患者进行了原发性扩展活检阴性(中位18核),并通过会阴会阴行SPBx术,进行了27芯(中位)。 210例(65.6%)患者的实质实质正常,110例在初次活检时有炎症反应(34.4%)(没有人抱怨症状提示在活检时诊断为急性前列腺炎)。此外,中位前列腺特异性抗原和异常直肠指检分别等于7.3 ng / ml和3.6%,而分别为8.2 ng / ml和3.8%。结果:320例患者中有66例(20.5%)被发现患有前列腺癌(PCa)。其中,分别有42例(63.6%)和24例(36.4%; p = 0.007)在组织活检时具有慢性前列腺炎和正常实质的组织学诊断。结论:在原发性活检中的炎症模式与重复SPBx时PCa发生率的降低无关。因此,只有对包括更多参数(即尿PCA3)的准确临床评估,才有希望选择在持续怀疑癌症的情况下需要进行活检的男性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号